Kelly Financial Services LLC Iterum Therapeutics PLC Transaction History

Kelly Financial Services LLC

  • $268 Million
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Jul 17, 2024
SELL
$0.21 - $2.9 $378 - $5,220
-1,800 Closed
0 $0
Q3 2021

Jul 17, 2024
SELL
$0.54 - $2.29 $1,273 - $5,399
-2,358 Reduced 56.71%
1,800 $1.01 Million
Q2 2021

Jul 17, 2024
BUY
$0.97 - $2.39 $2,287 - $5,635
2,358 Added 131.0%
4,158 $1.8 Million
Q1 2021

Jul 17, 2024
BUY
$0.97 - $2.73 $1,746 - $4,914
1,800 New
1,800 $2.54 Million

Others Institutions Holding ITRM

# of Institutions
1
Shares Held
66
Call Options Held
0
Put Options Held
0
View Full List

About Iterum Therapeutics plc

ITRM Quotes by TradingView
  • Ticker ITRM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 12,233,400
  • Market Cap $13.2M
  • Description
  • Iterum Therapeutics plc, a clinical-stage pharmaceutical company, engages in developing and commercializing anti-infectives in Ireland, Bermuda, and the United States. It is developing sulopenem, a novel anti-infective compound with oral and IV formulations that is in Phase III clinical trials for the treatment of uncomplicated urinary tract inf...
More about ITRM
Track This Portfolio

Track Kelly Financial Services LLC Portfolio

Follow Kelly Financial Services LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kelly Financial Services LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kelly Financial Services LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email